CYCLOPROPAMITOSENES, NOVEL BIOREDUCTIVE ANTICANCER AGENTS - SYNTHESIS, ELECTROCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF 7-SUBSTITUTED CYCLOPROPAMITOSENES AND RELATED INDOLEQUINONES
As. Cotterill et al., CYCLOPROPAMITOSENES, NOVEL BIOREDUCTIVE ANTICANCER AGENTS - SYNTHESIS, ELECTROCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF 7-SUBSTITUTED CYCLOPROPAMITOSENES AND RELATED INDOLEQUINONES, Journal of medicinal chemistry, 37(22), 1994, pp. 3834-3843
The synthesis of the indolequinones 8 and 9 starting from methyl 4-(be
nzyloxy)-5-methoxyindole-2-carboxylate (10) is described. The methoxy
group in the indolequinones 1, 2, 4, 5, and 7-9 can be displaced by va
rious nitrogen nucleophiles (ammonia, 2-methoxyethylamine, aziridine,
2-methylaziridine, pyrrolidine) in 22-88% yield. The resulting amino-s
ubstituted quinones, together with their methoxy precursors, were stud
ied by cyclic voltammetry to determine their reduction potentials, whi
ch, in DMF solution, lie in the range -1.355 to -1.597 V (vs ferrocene
). The cytotoxicity of the compounds towards aerobic and hypoxic mamma
lian cells was also determined; in general, under aerobic conditions,
the cyclopropamitosenes are more toxic than the corresponding pyrrolo[
1,2-alpha]indolequinones, which are in turn more toxic than the simple
1,2-dimethylindolequinones, with many of the compounds in each series
showing greater toxicity toward hypoxic cells.